1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. NECTAR LIFESCIENCES LTD.
Nectar Lifesciences Ltd. NSE: NECLIFE | BSE: 532649

Nectar Lifesciences Ltd. Live Share Price Today, Share Analysis and Chart

Value Stock, Under Radar
about

Nectar Lifescience sustainable production systems to manufacture APIs and Formulations. With an expertise in R&D, the Company has been experiencing growth in this segment. The Company is also in the Menthol business and succeeded in both domestic and...

Read More
20.72 -0.49 (-2.31%)
Near 52W Low of ₹20.02
1.9M
NSE+BSE Volume

NSE 23 Jun, 2025 3:40 PM (IST)

Watchlist

Portfolio

Alert

Share
Loading... You have run out of DVM views! Check usage
Subscribe now to see details
Durability score
High Financial Strength
75.0 / 100
Valuation Score
Affordable Valuation
68.3 / 100
Momentum Score
Technically Bearish
26.6 / 100
Value Stock, Under Radar These stocks are strong in quality and valuation, but score weak in technical aspects. Hence, it is better to wait for the stock to change their momentum. View Similar Embed DVM
Analyst Price Target
No estimates available

16

S

13

W

1

O

0

T

SWOT Analysis

Nectar Lifesciences Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..

Earnings Conference Calls, Investor Presentations and Annual Reports

All Earnings Calls
Annual Report Mar-2024
pdf
Annual Report Mar-2023
pdf
Annual Report Mar-2022
pdf
Annual Report Mar-2021
pdf
Annual Report Mar-2020
pdf
Annual Report Mar-2019
pdf
Annual Report Mar-2018
pdf
Annual Report Mar-2017
pdf
Annual Report Mar-2016
pdf
Annual Report Mar-2015
pdf
Annual Report Mar-2014
pdf
Annual Report Mar-2013
pdf
Annual Report Mar-2012
pdf
25 Nov, 2024 BRICKWORK RATINGS
Nectar Lifesciences Limited
Issuer did not cooperate; Based on best available information; Long Term Rating Continues to be in ISSUER NOT COOPERATING* category/Downgraded …
pdf
28 Oct, 2024 CARE RATINGS
Nectar Lifesciences Limited
pdf
13 Sep, 2024 BRICKWORK RATINGS
Nectar Lifesciences Limited
Issuer did not cooperate; Based on best available information; Rating moved to Not Reviewed Advisory;
09 Sep, 2024 BRICKWORK RATINGS
Nectar Lifesciences Limited
Issuer did not cooperate; Based on best available information; Rating moved to Not Reviewed Advisory;
06 Sep, 2024 BRICKWORK RATINGS
Nectar Lifesciences Limited
Issuer did not cooperate; Based on best available information; Rating moved to Not Reviewed Advisory;
04 Sep, 2024 BRICKWORK RATINGS
Nectar Lifesciences Limited
Issuer did not cooperate; Based on best available information; Rating moved to Not Reviewed Advisory;
26 Mar, 2024 CARE RATINGS
Nectar Lifesciences Limited
pdf
30 Aug, 2023 BRICKWORK RATINGS
Nectar Lifesciences Limited
Issuer did not cooperate; Based on best available information; Long Term Rating Downgraded to BWR B; Short Term Rating Reaffirmed;
pdf
06 Jul, 2022 BRICKWORK RATINGS
Nectar Lifesciences Limited
Outstanding Ratings Upgraded;
pdf
15 Jul, 2021 BRICKWORK RATINGS
Nectar Lifesciences Limited
Amended Rationale;
pdf
12 Jul, 2021 BRICKWORK RATINGS
Nectar Lifesciences Limited
Outstanding Ratings Downgraded;
pdf
22 Feb, 2021 BRICKWORK RATINGS
Nectar Lifesciences Limited
Ratings Downgraded and Placed on Credit Watch with Negative Implications
pdf
All Credit Ratings
31 Jan, 2025 BSE INDIA
NECTAR LIFESCIENCES LTD. - 532649 - Announcement under Regulation 30 (LODR)-Inv…
NECTAR LIFESCIENCES LTD. - 532649 - Announcement under Regulation 30 (LODR)-Inv…
pdf link
14 Nov, 2024 BSE INDIA
NECTAR LIFESCIENCES LTD. - 532649 - Announcement under Regulation 30 (LODR)-Inv…
NECTAR LIFESCIENCES LTD. - 532649 - Announcement under Regulation 30 (LODR)-Inv…
pdf link

Nectar Lifesciences Ltd. FAQ

How is Nectar Lifesciences Ltd. today?
Nectar Lifesciences Ltd. today is trading in the red, and is down by -2.31% at 20.72.
Nectar Lifesciences Ltd. is currently trading down -2.31% on an intraday basis. In the past week the stock fell -11.64%. stock has been down -16.22% in the past quarter and fell -37.06% in the past year. You can view this in the overview section.